For the quarter ending 2026-03-31, JYNT had -$2,875,124 decrease in cash & cash equivalents over the period. -$1,710,770 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 1,299,135 | 991,097 | 855,009 | 93,363 |
| Depreciation and amortization | 404,449 | 442,943 | 463,046 | 419,414 |
| Deferred income taxes | - | 93,066 | 0 | 0 |
| Assets and liabilities held for sale, net | - | - | 0 | 0 |
| Net loss on disposition or impairment | -403,090 | -1,696,046 | -860,597 | -1,756,935 |
| Net franchise fees recognized upon termination of franchise agreements | 306,594 | 89,300 | 83,512 | 74,167 |
| Provision for credit losses | 85,216 | 136,513 | 149,719 | - |
| Stock-based compensation expense | 280,000 | 326,295 | 346,209 | 330,988 |
| Accounts receivable | -460,366 | -70,528 | 94,157 | -95,629 |
| Prepaid expenses and other current assets | 982,100 | -389,508 | -1,319,084 | -273,445 |
| Deferred franchise costs | -194,015 | -164,206 | -199,147 | -9,975 |
| Deposits and other assets | -23,278 | -14,004 | 37,612 | -2,418 |
| Accounts payable | -678,729 | 258,776 | -558,828 | 390,479 |
| Accrued expenses | 527,224 | 481,507 | -67,300 | -419,496 |
| Payroll liabilities | -2,122,582 | 85,548 | 521,158 | -371,037 |
| Operating leases | -805,391 | -1,259,310 | -1,124,332 | -1,440,987 |
| Deferred revenue | -133,506 | 199,286 | -1,135,131 | -263,436 |
| Upfront regional developer fees | -105,714 | -69,919 | -69,919 | -72,375 |
| Other liabilities | -18,327 | -1,033,312 | 229,854 | 137,501 |
| Net cash used in operating activities | -1,476,170 | 2,897,482 | 1,773,032 | 868,649 |
| Proceeds from sale of clinics | 0 | 0 | 0 | 7,738,187 |
| Purchase of property and equipment | 234,600 | 349,400 | 317,840 | 505,040 |
| Net cash used in investing activities | -234,600 | -349,400 | -317,840 | 7,233,147 |
| Payments of finance lease obligation | 0 | 0 | 0 | 0 |
| Related To Tax Withholding For Share Based Compensation | 56,528 | 0 | 8,440 | - |
| Repayment of debt under the credit agreement | - | 0 | 0 | 0 |
| For Repurchase Of Common Stock | 1,145,054 | 9,024,589 | 2,280,554 | 0 |
| Proceeds from exercise of stock options | 37,228 | 65,240 | 547,582 | 0 |
| Net cash (used in) provided by financing activities | -1,164,354 | -8,959,349 | -1,741,412 | 0 |
| Decrease in cash, cash equivalents and restricted cash | -2,875,124 | -6,411,267 | -286,220 | 8,101,796 |
| Cash, cash equivalents and restricted cash, beginning of period | 24,301,868 | 30,713,135 | 25,996,436 | - |
| Cash, cash equivalents and restricted cash, end of period | 21,426,744 | 24,301,868 | 30,713,135 | - |
JOINT Corp (JYNT)
JOINT Corp (JYNT)